Pasithea Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Pasithea Therapeutics has a total shareholder equity of $23.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $26.1M and $2.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$16.33m |
Equity | US$23.40m |
Total liabilities | US$2.72m |
Total assets | US$26.12m |
Financial Position Analysis
Short Term Liabilities: KTTA's short term assets ($16.7M) exceed its short term liabilities ($2.6M).
Long Term Liabilities: KTTA's short term assets ($16.7M) exceed its long term liabilities ($84.4K).
Debt to Equity History and Analysis
Debt Level: KTTA is debt free.
Reducing Debt: KTTA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KTTA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: KTTA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 69.6% each year